Glycobius speciosus (Say) was studied in New York State to elucidate poorly known aspects of its biology. Head capsule size from excavated larvae coupled with gallery lengths measured at the time of excavation was used to characterize larval development. Partial life tables indicated nearly 20% of G. speciosus survive to adulthood. Larvae experienced 30% of their mortality during early development, 27% during mid-larval development, and 43% during late larval development. Predation by hairy woodpeckers, Dryobates villosus (Linnaeus) (Piciformes: Picidae), the only unambiguous source of mortality, accounted for 43% mortality in naturally infested trees located and followed 2004–2009, and 74% late instar mortality. One parasitoid, Dolichomitus irritator (Fabricius) (Hymenoptera: Ichneumonidae), was recovered from a single larva. Beetles emerged between 316 accumulated DD (base 10 °C) and 648 DD. Males emerged prior to, or simultaneously with, females and lived longer. Female fecundity averaged 41.3 ± 6 eggs. Larval eclosion occurred 7–10 days after oviposition. Non-functional ovipositors observed in 16% of females represented an appreciable reproductive loss. In 77% of infested trees 1 oviposition site was located and in 70% of oviposition sites examined only 1 or 2 larvae successfully eclosed, penetrated the bark to the phloem-xylem interface, and began feeding. Beetles preferred southern and eastern aspects for oviposition which occurred preferentially on the lower bole (<20 cm). Male beetles had longer and wider antennae than females, pronotal pits containing gland pores, and a straight to concave posterior margin of the terminal sternite compared to the more rounded margin of females.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.